Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects

Author(s): Hua Cao, Kai Wang, Yang-Liang Ye and Jian-Hua Shen *

Volume 24, Issue 35, 2017

Page: [3921 - 3937] Pages: 17

DOI: 10.2174/0929867324666170810154414

Price: $65

Abstract

Background: Intestine targeted drugs are orally administered compounds exerting their therapeutic effects locally in the intestinal tract, thus avoiding side effects related to systemic exposure.

Objective: Both academic and pharmaceutical research has, therefore, focused on such agents, but the systematic methodology needed for their design and evaluation has been unclear. Thus, careful summary of this kind of drugs is vital for drug design.

Method: This review summarizes achievements from 2013 to 2016, through literatures, patents and related websites, in developing orally administrated small molecule drugs with intestine targeted profile.

Results: This review summarized six categories of intestine targeted drugs, based on various design strategies, with careful analysis of recent examples from each category.

Conclusion: Our analysis indicated that the intestine targeted profile could expand the therapeutic window of drugs while retaining their efficacy. Thus, we describe simple approaches suitable for rational design of intestine targeted drugs.

Keywords: Intestine targeted drugs, design strategies, lipophilicity, aqueous solubility, molecular weight, soft drugs, prodrugs, efflux transporters.

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy